Predicting the molecular subtypes of breast cancer using nomograms based on three-dimensional ultrasonography characteristics
- PMID: 36059623
- PMCID: PMC9437331
- DOI: 10.3389/fonc.2022.838787
Predicting the molecular subtypes of breast cancer using nomograms based on three-dimensional ultrasonography characteristics
Abstract
Background: Molecular subtyping of breast cancer is commonly doneforindividualzed cancer management because it may determines prognosis and treatment. Therefore, preoperativelyidentifying different molecular subtypes of breast cancery can be significant in clinical practice.Thisretrospective study aimed to investigate characteristic three-dimensional ultrasonographic imaging parameters of breast cancer that are associated with the molecular subtypes and establish nomograms to predict the molecular subtypes of breast cancers.
Methods: A total of 309 patients diagnosed with breast cancer between January 2017and December 2019 were enrolled. Sonographic features were compared between the different molecular subtypes. A multinomial logistic regression model was developed, and nomograms were constructed based on this model.
Results: The performance of the nomograms was evaluated in terms of discrimination and calibration.Variables such as maximum diameter, irregular shape, non-parallel growth, heterogeneous internal echo, enhanced posterior echo, lymph node metastasis, retraction phenomenon, calcification, and elasticity score were entered into the multinomial model.Three nomograms were constructed to visualize the final model. The probabilities of the different molecular subtypes could be calculated based on these nomograms. Based on the receiver operating characteristic curves of the model, the macro-and micro-areaunder the curve (AUC) were0.744, and 0.787. The AUC was 0.759, 0.683, 0.747 and 0.785 for luminal A(LA), luminal B(LB), human epidermal growth factor receptor 2-positive(HER2), and triple-negative(TN), respectively.The nomograms for the LA, HER2, and TN subtypes provided good calibration.
Conclusions: Sonographic features such as calcification and posterior acoustic features were significantly associated with the molecular subtype of breast cancer. The presence of the retraction phenomenon was the most important predictor for the LA subtype. Nomograms to predict the molecular subtype were established, and the calibration curves and receiver operating characteristic curves proved that the models had good performance.
Keywords: breast cancer; molecular subtypes; nomogram; relevance of three-dimensional ultrasonography; ultrasonography.
Copyright © 2022 Xu, Lu, Zhu, Tan, Yu and Bao.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





Similar articles
-
Construction of Nomograms for Predicting Pathological Complete Response and Tumor Shrinkage Size in Breast Cancer.Cancer Manag Res. 2020 Sep 10;12:8313-8323. doi: 10.2147/CMAR.S270687. eCollection 2020. Cancer Manag Res. 2020. PMID: 32982426 Free PMC article.
-
A nomogram to predict the high-risk RS in HR+/HER2-breast cancer patients older than 50 years of age.J Transl Med. 2021 Feb 16;19(1):75. doi: 10.1186/s12967-021-02743-3. J Transl Med. 2021. PMID: 33593381 Free PMC article.
-
Establishment of Simple Nomograms for Predicting Axillary Lymph Node Involvement in Early Breast Cancer.Cancer Manag Res. 2020 Mar 18;12:2025-2035. doi: 10.2147/CMAR.S241641. eCollection 2020. Cancer Manag Res. 2020. PMID: 32256110 Free PMC article.
-
A mathematical prediction model incorporating molecular subtype for risk of non-sentinel lymph node metastasis in sentinel lymph node-positive breast cancer patients: a retrospective analysis and nomogram development.Breast Cancer. 2018 Nov;25(6):629-638. doi: 10.1007/s12282-018-0863-7. Epub 2018 Apr 25. Breast Cancer. 2018. PMID: 29696563
-
Clinical features of patients with HER2-positive breast cancer and development of a nomogram for predicting survival.ESMO Open. 2021 Aug;6(4):100232. doi: 10.1016/j.esmoop.2021.100232. Epub 2021 Aug 13. ESMO Open. 2021. PMID: 34392135 Free PMC article.
Cited by
-
Prediction model for assessing HER2 status patient with invasive ductal carcinoma based on clinical parameters and ultrasound features: a dual-center study.BMC Womens Health. 2025 Jul 3;25(1):291. doi: 10.1186/s12905-025-03828-7. BMC Womens Health. 2025. PMID: 40611065 Free PMC article.
-
Exploring Biomarkers in Breast Cancer: Hallmarks of Diagnosis, Treatment, and Follow-Up in Clinical Practice.Medicina (Kaunas). 2024 Jan 17;60(1):168. doi: 10.3390/medicina60010168. Medicina (Kaunas). 2024. PMID: 38256428 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous